Dr Ruth Barrett
Associate Director, Operations
Dr Ruth Barrett has almost 20 years’ experience in commercial healthcare around IP management and licensing, negotiation, business development, fund raising & new company creation, corporate governance and project & alliance management. Ruth holds a PhD from Cambridge and an MA from Oxford University. Ruth is also currently an Observer at PepGen Inc.
Prior to joining OxSonics, Ruth commercialised healthcare IP arising from Oxford University, most notably through creation of EvOx Therapeutics, Osler Diagnostics and PepGen raising a total of £14.5M and concluded many other licensing, option and material sale transactions. Before this, Ruth was a business development consultant at PharmaVentures with a particular focus on M&A in API manufacturing, and before this a senior scientist in drug discovery at Daniolabs.